查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1657022

2025 年组织诊断全球市场报告

Tissue Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年组织诊断的市场规模将快速成长。到 2029 年，这一数字将成长至 106.7 亿美元，复合年增长率为 13.5%。预测期内的成长将归因于个人化医疗的成长、液态切片的兴起、人工智慧和机器学习的采用、远端病理学的扩展以及微创技术。预测期内的主要趋势包括数位病理学、人工智慧 (AI)、远端病理学服务、多重染色和成像以及基因组资料整合。

预计未来几年癌症发生率的上升将推动组织诊断市场的成长。当基因改变导致细胞不受控制地生长，破坏身体组织并形成肿块（即肿瘤）时，癌症就开始了。基因突变、致癌物质、吸烟、肥胖、辐射和荷尔蒙等各种因素都会导致癌症的发展。随着癌症患者数量的增加，对组织诊断等诊断程序的需求将会增加，这对于确定疾病的进展至关重要。例如，2024年2月，总部设在瑞士的联合国机构世界卫生组织（WHO）预测，2050年将有超过3,500万例癌症新病例，比2022年预计的2,000万例增加77%。因此，癌症发生率的上升正在刺激组织诊断市场的扩张。

医疗保健支出的增加预计将推动组织诊断市场的成长。医疗保健支出是指一定时期内国家或个人在医疗保健服务、治疗和产品上花费的总金额。这些支出将用于支援先进诊断技术、研究和医疗保健基础设施（包括组织诊断）的开发、取得和利用。例如，2024年7月，美国非营利组织美国医学会报告称，2012年至2022年处方药的复合年增长率最高，为4.7%，而医院护理的复合年增长率为4.4%，医生服务的复合年增长率为4.2%。医疗保健支出的增加将推动诊断技术的进步，从而促进组织诊断市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球组织诊断PESTEL分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球组织诊断市场：成长率分析
  • 全球组织诊断市场表现：规模与成长，2019 年至 2024 年
  • 全球组织诊断市场预测：2024-2029 年及 2034 年规模与成长
  • 全球组织诊断总目标市场 (TAM)

第六章 市场细分

  • 全球组织诊断市场：依产品、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 抗体
  • 套件
  • 试剂
  • 探测
  • 装置
  • 玻片染色系统
  • 扫描器
  • 组织处理系统
  • 全球组织诊断市场（按技术、效能和预测）2019-2024 年、2024-2029 年、2034 年
  • 免疫组织化学 (IHC)
  • 原位杂交（ISH）
  • 数位病理学和工作流程管理
  • 特殊染色
  • 全球组织诊断市场：依疾病、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 乳癌
  • 胃癌
  • 淋巴瘤
  • 摄护腺癌
  • 非小细胞肺癌（NSCLC）
  • 全球组织诊断市场依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 实验室
  • 製药公司
  • 受託研究机构
  • 全球组织诊断市场：耗材细分、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 切片穿刺针
  • 玻片和盖玻片
  • 组织包埋材料
  • 全球组织诊断市场：抗体细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 一抗
  • 二抗
  • 单株抗体
  • 多株抗体
  • 全球组织诊断市场：套件细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断套件
  • 检测试剂套件
  • 染色试剂套件
  • 全球组织诊断市场：试剂细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 稳定剂
  • 染色试剂
  • 抗原修復解决方案
  • 全球组织诊断市场：探针细分、类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 萤光探针
  • 分子探针
  • 杂合反应探针
  • 全球组织诊断市场：设备细分、类型、效能与预测，2019-2024 年、2024-2029 年、2034 年
  • 显微镜
  • 组织微阵列仪
  • 雷射捕获晶粒仪
  • 全球组织诊断市场：玻片染色系统的细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自动染色设备
  • 手动染色系统
  • 全球组织诊断市场：扫描器细分市场、类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 数位幻灯片扫描仪
  • 全幻灯片成像系统
  • 全球组织诊断市场：组织处理系统细分、类型、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 组织处理装置
  • 嵌入式中心
  • 切片机

第七章 区域和国家分析

  • 全球组织诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球组织诊断市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 组织诊断市场：竞争格局
  • 组织诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Merck KGaA
  • BioGenex Laboratories
  • Sakura Finetek Co. Ltd.
  • Philips Healthcare NV
  • Bio-Rad Laboratories
  • Ventana Medical Systems Inc.
  • Hologic Inc.
  • Becton Dickinson and Company
  • Sysmex Corporation
  • Cell Signaling Technology Inc.
  • Enzo Life Sciences Inc.
  • Epitomics Inc.
  • Fluidigm Corporation
  • GE Healthcare Technologies Inc.
  • Genomic Health Inc.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年组织诊断市场：提供新机会的国家
  • 2029 年组织诊断市场：细分市场将带来新机会
  • 组织诊断市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r22216

Tissue diagnostic refers to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions, including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

The main types of products in tissue diagnostic are consumables, antibodies, kits, reagents, probes, instrument, slide staining system, scanner and tissue processing system. The antibodies are used for the detection of infections, recognition of allergies, and the measurement of hormones and other biological markers in the blood in tissue diagnostics. The technologies used in tissue diagnostic are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management and special staining to detect diseases such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small cell lung cancer (NSCLC). Tissue diagnostic is mostly used in hospitals, research laboratories, pharmaceutical companies, and contract research organizations.

The tissue diagnostic market research report is one of a series of new reports from The Business Research Company that provides tissue diagnostic market statistics, including tissue diagnostic industry global market size, regional shares, competitors with a tissue diagnostic market share, detailed tissue diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the tissue diagnostic industry. This tissue diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue diagnostic market size has grown rapidly in recent years. It will grow from $5.77 billion in 2024 to $6.44 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to aging population, cancer prevalence, technological advancements, increased disease awareness, pathology workflow efficiency

The tissue diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.67 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to personalized medicine growth, rise of liquid biopsies, ai and machine learning adoption, telepathology expansion, minimally invasive techniques. Major trends in the forecast period include digital pathology, artificial intelligence (ai), telepathology services, multiplex staining and imaging, integration of genomic data.

The increasing incidence of cancer is expected to drive the growth of the tissue diagnostic market in the coming years. Cancer begins when genetic changes cause cells to grow uncontrollably, destroying body tissue and forming a mass known as a tumor, which can be either cancerous or benign. Various factors, including genetic mutations, carcinogens, smoking, obesity, radiation, and hormones, can lead to the development of cancer. As cancer cases rise, the demand for diagnostic procedures like tissue diagnostics will grow, as these are essential in determining the disease's progression. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would rise to over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the rising cancer incidence is fueling the expansion of the tissue diagnostic market.

The increasing healthcare expenditure is expected to drive the growth of the tissue diagnostic market. Healthcare expenditure refers to the total amount of money spent on healthcare services, treatments, and products over a certain period, either at the national or individual level. This spending supports the development, accessibility, and utilization of advanced diagnostic technologies, research, and medical infrastructure, including tissue diagnostics. For example, in July 2024, the American Medical Association, a US-based nonprofit organization, reported that from 2012 to 2022, the average annual growth rate for prescription drugs was the highest at 4.7%, compared to 4.4% for hospital care and 4.2% for physician services. This increase in healthcare spending helps foster advancements in diagnostic technologies, driving the growth of the tissue diagnostic market.

Product innovation is a growing trend in the tissue diagnostic market, with companies introducing advanced products and solutions that can collect multiple sample types, test multiple samples simultaneously, automate lab operations, and make diagnostics more accessible. Leading players are focusing on developing automated tissue diagnostic systems to gain a competitive advantage and boost revenue. For instance, in June 2022, Roche, a Switzerland-based healthcare company, launched the BenchMark ULTRA PLUS system for cancer diagnostics. This tissue staining system features optimized workflow, enhanced testing efficiency, and sustainable environmental features, allowing pathologists to deliver high-quality, timely results to doctors and patients. Key innovations in the system include intuitive software, remote monitoring capabilities, an integrated touchscreen for a better user experience, and environmentally sustainable waste management and packaging.

The technological advancements, particularly the integration of artificial intelligence (AI), are influencing the tissue diagnostic market. AI is employed to analyze medical images and pathological data, enhancing the accuracy and efficiency of disease detection and classification. For instance, in 2023, Qritive introduced the Qai Prostate, an AI-powered prostate cancer detection tool, providing pathologists with advanced capabilities for detecting and classifying malignant and benign tumor locations in biopsy tissue samples. This integration of AI represents a strategic move to improve precision in cancer diagnosis and treatment within the tissue diagnostic market.

In February 2022, Labcorp's acquisition of Personal Genome Diagnostics (PGDx) for $575 million stands out. This move strengthens Labcorp's next-generation sequencing-based genomic profiling capabilities and enhances existing liquid biopsy capabilities, reflecting the industry's commitment to advancing cancer genomics.

Major companies operating in the tissue diagnostic market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc.

North America was the largest region in the tissue diagnostic market in 2024. The regions covered in the global tissue diagnostic industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the tissue diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The tissue diagnostic market includes revenues earned by entities by consumables and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Consumables; Antibodies; Kits; Reagents; Probes; Instruments; Slide Staining System; Scanner; Tissue Processing system
  • 2) By Technology: Immunohistochemistry (IHC); In Situ Hybridization (ISH); Digital Pathology And Workflow Management; Special Staining
  • 3) By Disease: Breast Cancer; Gastric Cancer; Lymphoma; Prostate Cancer; Non-Small Cell Lung Cancer (NSCLC)
  • 4) By End User: Hospitals; Research Laboratories; Pharmaceutical Companies; Contract Research Organizations
  • Subsegments:
  • 1) By Consumables: Biopsy Needles; Slides And Cover Slips; Tissue Embedding Materials
  • 2) By Antibodies: Primary Antibodies; Secondary Antibodies; Monoclonal Antibodies; Polyclonal Antibodies
  • 3) By Kits: Diagnostic Kits; Assay Kits; Staining Kits
  • 4) By Reagents: Fixatives; Staining Reagents; Antigen Retrieval Solutions
  • 5) By Probes: Fluorescent Probes; Molecular Probes; Hybridization Probes
  • 6) By Instruments: Microscopes; Tissue Microarray Instruments; Laser Capture Microdissection Instruments
  • 7) By Slide Staining System: Automated Stainers; Manual Staining Systems
  • 8) By Scanner: Digital Slide Scanners; Whole Slide Imaging Systems
  • 9) By Tissue Processing System: Tissue Processors; Embedding Centers; Microtomes
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Danaher Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Diagnostic Market Characteristics

3. Tissue Diagnostic Market Trends And Strategies

4. Tissue Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tissue Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tissue Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tissue Diagnostic Market Growth Rate Analysis
  • 5.4. Global Tissue Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tissue Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tissue Diagnostic Total Addressable Market (TAM)

6. Tissue Diagnostic Market Segmentation

  • 6.1. Global Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
  • Instruments
  • Slide Staining System
  • Scanner
  • Tissue Processing system
  • 6.2. Global Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Digital Pathology And Workflow Management
  • Special Staining
  • 6.3. Global Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
  • 6.4. Global Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
  • 6.5. Global Tissue Diagnostic Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopsy Needles
  • Slides And Cover Slips
  • Tissue Embedding Materials
  • 6.6. Global Tissue Diagnostic Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Antibodies
  • Secondary Antibodies
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • 6.7. Global Tissue Diagnostic Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Kits
  • Assay Kits
  • Staining Kits
  • 6.8. Global Tissue Diagnostic Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fixatives
  • Staining Reagents
  • Antigen Retrieval Solutions
  • 6.9. Global Tissue Diagnostic Market, Sub-Segmentation Of Probes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescent Probes
  • Molecular Probes
  • Hybridization Probes
  • 6.10. Global Tissue Diagnostic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microscopes
  • Tissue Microarray Instruments
  • Laser Capture Microdissection Instruments
  • 6.11. Global Tissue Diagnostic Market, Sub-Segmentation Of Slide Staining System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Stainers
  • Manual Staining Systems
  • 6.12. Global Tissue Diagnostic Market, Sub-Segmentation Of Scanner, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Digital Slide Scanners
  • Whole Slide Imaging Systems
  • 6.13. Global Tissue Diagnostic Market, Sub-Segmentation Of Tissue Processing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Processors
  • Embedding Centers
  • Microtomes

7. Tissue Diagnostic Market Regional And Country Analysis

  • 7.1. Global Tissue Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tissue Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Diagnostic Market

  • 8.1. Asia-Pacific Tissue Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Diagnostic Market

  • 9.1. China Tissue Diagnostic Market Overview
  • 9.2. China Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Diagnostic Market

  • 10.1. India Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Diagnostic Market

  • 11.1. Japan Tissue Diagnostic Market Overview
  • 11.2. Japan Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Diagnostic Market

  • 12.1. Australia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Diagnostic Market

  • 13.1. Indonesia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Diagnostic Market

  • 14.1. South Korea Tissue Diagnostic Market Overview
  • 14.2. South Korea Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Diagnostic Market

  • 15.1. Western Europe Tissue Diagnostic Market Overview
  • 15.2. Western Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Diagnostic Market

  • 16.1. UK Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Diagnostic Market

  • 17.1. Germany Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Diagnostic Market

  • 18.1. France Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Diagnostic Market

  • 19.1. Italy Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Diagnostic Market

  • 20.1. Spain Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Diagnostic Market

  • 21.1. Eastern Europe Tissue Diagnostic Market Overview
  • 21.2. Eastern Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Diagnostic Market

  • 22.1. Russia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Diagnostic Market

  • 23.1. North America Tissue Diagnostic Market Overview
  • 23.2. North America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Diagnostic Market

  • 24.1. USA Tissue Diagnostic Market Overview
  • 24.2. USA Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Diagnostic Market

  • 25.1. Canada Tissue Diagnostic Market Overview
  • 25.2. Canada Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Diagnostic Market

  • 26.1. South America Tissue Diagnostic Market Overview
  • 26.2. South America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Diagnostic Market

  • 27.1. Brazil Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Diagnostic Market

  • 28.1. Middle East Tissue Diagnostic Market Overview
  • 28.2. Middle East Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Diagnostic Market

  • 29.1. Africa Tissue Diagnostic Market Overview
  • 29.2. Africa Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Diagnostic Market Competitive Landscape
  • 30.2. Tissue Diagnostic Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Diagnostic Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. BioGenex Laboratories
  • 31.3. Sakura Finetek Co. Ltd.
  • 31.4. Philips Healthcare NV
  • 31.5. Bio-Rad Laboratories
  • 31.6. Ventana Medical Systems Inc.
  • 31.7. Hologic Inc.
  • 31.8. Becton Dickinson and Company
  • 31.9. Sysmex Corporation
  • 31.10. Cell Signaling Technology Inc.
  • 31.11. Enzo Life Sciences Inc.
  • 31.12. Epitomics Inc.
  • 31.13. Fluidigm Corporation
  • 31.14. GE Healthcare Technologies Inc.
  • 31.15. Genomic Health Inc.

32. Global Tissue Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Diagnostic Market

34. Recent Developments In The Tissue Diagnostic Market

35. Tissue Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Tissue Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tissue Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tissue Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer